Fundamentals of Drug Safety and Pharmacovigilance

-

The challenge of maximizing drug safety and maintaining public confidence has become increasingly complex. Pharmaceutical and biotechnology companies must not only monitor, but also proactively assess and manage drug risk throughout a product’s lifecycle, from development to post market. 
20th World Conference on Pharmaceutical Chemistry and Drug Design is going to be held in Dubai during September 03-05 2018, under the enclosed title "Pharmacovigilance"

https://drug-chemistry.pharmaceuticalconferences.com/


Pharmacovigilance: WHO defined as 'the pharmacological science and activities relating to the detection, assessment, understanding and prevention of adverse effects or any other drug-related problem’
An umbrella term used to describe the processes for monitoring and evaluating ADRs is a key component of effective drug regulation systems, clinical practice and public health programs.
It is the study of the safety of marketed drugs examined under the practical conditions of clinical use in large communities.
Drugs appear to be safe and well-tolerated, but the safety in the ‘real world’ is unclear- Chronically/repeatedly use of drugs, Use with other drugs
Safety in vulnerable groups is unknown- Pregnant women & breastfeeding mother, elderly, young children
Significant harm to a few patients, rumors and myths- can destroy the credibility, adherence to and success of a treatment.
Pharmacovigilance provide evidence- medicine-related problems: treatment failure, counterfeit/poor quality medicines, drug interactions, incorrect use.
Generate evidence that will inspire public confidence and trust.

ImprovingPharmacovigilance
Increase the awareness of healthcare professionals and the public on the understanding of importance of pharmacovigilance, Develop and promote an effective channel for ADR reporting, such as online reporting system, All the parties involved in pharmacovigilance reporting are coordinated under a platform from BPOM , A centralized database for safety reports to facilitate systematic follow up and detailed analyses, Improve communication among stakeholders in the reporting of adverse events such as, the regulator, the health care providers, and manufacturer for pharmacovigilance.

Roza Palv
Program Manager-Pharma Chem 2018
Contact: pharmaceuticalchemistry@pharmameetings.com


Comments

Post a Comment

Popular posts from this blog

Nanomedicine & Women’s Health

-
Image
Nanomedicine have the potential to revolutionize the diagnosis, prevention, and treatment of a range of conditions and diseases affecting women’s health Nanomedicine is the application of  nanotechnology  in the field of medicine with a view to enhancing the diagnosis and treatment of various diseases. Nanotechnology is already involved in a range of biomedical applications including drug and vaccine delivery, diagnostic imaging, nanosensor diagnostics, nano-enabled therapies, and tissue engineering. A growing recognition of the specific health care requirements of women has resulted in the proposed organizational changes in the provision of health care, focusing predominantly on a life course approach to women’s health care. As our understanding of the benefits of nanomaterial-based agents and diagnostics continues to grow in terms of selectivity, sensitivity, affinity, and detection limits, there is a widespread anticipation that nanotechnology will play an increasing rol
Read more

Drug Development with Translational Pharmaceutics

-
Image
As the   pharmaceutical   industry faces increasing pressure to accelerate drug development, many contract development organizations are recommending early development programs.   Scientists discussed the current roadblocks in the traditional   drug development   process and explains how productivity can be improved and timelines shortened by implementing a new approach the company refers to as Translational Pharmaceutics.   Be the part of   20th World Conference on Pharmaceutical Chemistry and Drug Design   in Dubai, UAE during September 03-05, 2018. Describe the state of affairs of researches, thesis, projects and enlighten us with your innovation and meet pharmacists, apothecaries, druggists, scientists, experts and technologists. https://drug-chemistry.pharmaceuticalconferences.com There are many factors that can delay the development and eventual commercialization of   novel therapeutics . One of the most intractable factors is the conventional trial-and-error approach
Read more

20th World Conference on Pharmaceutical Chemistry and Drug Design

-
Image
Drug design is an inventive process of medication discovered by biological target. It is also known as rational drug design or rational design. The drug is most commonly an organic small molecule that activates or inhibits the function of a biomolecule such as a protein, which in turn results in a therapeutic benefit to the patient. In the most basic sense. Drug design relies on the knowledge of the three-dimensional structure of bioactive sites. The drug is an active molecule, when it is predicament to target site it can either inhibit or activate the function of a biomolecule which effects in therapeutic benefit. The main objective in drug design is to foresee whether a given particle will bind to a target and if so how unequivocally. Molecular mechanics or molecular dynamics are regularly used to predict the conformation of the little particle and to model conformational changes in the biological targets that may happen when the little molecules ties to it.   The us
Read more